CAR-T cell therapy (Miltenyi Biotec/University Medical Center Goettingen/Max-Planck Institute for Experimental Medicine)

N/A

Report date: 2025/06/11 11:07:28

Base Information

Drug NameCAR-T cell therapy (Miltenyi Biotec/University Medical Center Goettingen/Max-Planck Institute for Experimental Medicine)
Drug Alias NameTanCAR T-cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Medical Center Goettingen
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GoettingenMax Planck Institut fur Experimentelle MedizinMiltenyi Biotec BV & Co KG
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A